ORLEANS CAPITAL MANAGEMENT CORP/LA

Position in JNJ — Johnson & Johnson

CIK 1013234 MANDEVILLE, LA

Position in JNJ

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,128,268

+$569,719 QoQ

Shares Held

8,380

+31.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.43%

of 13F equity value

Holder Rank

#2,299

of 4,676 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ORLEANS CAPITAL MANAGEMENT CORP/LA holds $9,372,735 across 5 Drug Manufacturers - General names. JNJ ranks #2 (22.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	18,649	$4,692,834
2	JNJ	Johnson & Johnson This page	8,380	$2,128,268
3	GILD	Gilead Sciences, Inc.	14,186	$1,792,259
4	MRK	Merck & Co., Inc.	3,472	$446,152
5	BMY	Bristol Myers Squibb Co	5,436	$313,222

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,128,268	8,380	+31.4%	Shares	Sole	2026-08-12
2026-03-31	$1,558,549	6,376	+325.4%	Shares	Sole	2026-05-14
2025-12-31	$310,218	1,499	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.